Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M83,973Revenue $M16,385Net Margin (%)15.6Z-Score5.2
Enterprise Value $M84,587EPS $1.5Operating Margin %18.9F-Score5
P/E(ttm))31.4Cash Flow Per Share $2.8Pre-tax Margin (%)17.6Higher ROA y-yY
Price/Book5.510-y EBITDA Growth Rate %0.4Quick Ratio1.6Cash flow > EarningsY
Price/Sales5.25-y EBITDA Growth Rate %-13.5Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %184ROA % (ttm)6.6Higher Current Ratio y-yY
Dividend Yield %2.8Insider Buy (3m)0ROE % (ttm)16.9Less Shares Outstanding y-yN
Payout Ratio %89.0Shares Outstanding M1,657ROI % (ttm)5.7Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYVanguard Health Care Fund 2014-06-30 Add0.86%$46.59 - $52.19
($49.29)
$ 50.653%Add 22.96%36,197,961
BMYJoel Greenblatt 2014-06-30 Buy 0.05%$46.59 - $52.19
($49.29)
$ 50.653%New holding, 89363 sh.89,363
BMYRay Dalio 2014-06-30 Sold Out $46.59 - $52.19
($49.29)
$ 50.653%Sold Out0
BMYRonald Muhlenkamp 2014-03-31 Buy 1.9%$48.54 - $56.61
($53.23)
$ 50.65-5%New holding, 212015 sh.212,015
BMYVanguard Health Care Fund 2014-03-31 Add0.73%$48.54 - $56.61
($53.21)
$ 50.65-5%Add 20.35%29,437,761
BMYRay Dalio 2014-03-31 Buy $48.54 - $56.61
($53.23)
$ 50.65-5%New holding, 4428 sh.4,428
BMYGeorge Soros 2014-03-31 Sold Out -0.05%$48.54 - $56.61
($53.23)
$ 50.65-5%Sold Out0
BMYJoel Greenblatt 2014-03-31 Sold Out -0.02%$48.54 - $56.61
($53.23)
$ 50.65-5%Sold Out0
BMYJoel Greenblatt 2013-12-31 Buy 0.02%$46.41 - $53.84
($50.96)
$ 50.65-1%New holding, 11679 sh.11,679
BMYVanguard Health Care Fund 2013-09-30 Add0.64%$41.32 - $47.53
($43.84)
$ 50.6516%Add 20.26%24,459,861
BMYJean-Marie Eveillard 2013-09-30 Reduce-0.01%$41.32 - $47.53
($43.84)
$ 50.6516%Reduce -75.17%16,520
BMYVanguard Health Care Fund 2013-06-30 Add0.39%$39.68 - $47.68
($43.41)
$ 50.6517%Add 13.32%20,338,461
BMYGeorge Soros 2013-06-30 Buy 0.05%$39.68 - $47.68
($43.41)
$ 50.6517%New holding, 100000 sh.100,000
BMYJean-Marie Eveillard 2013-06-30 Add0.01%$39.68 - $47.68
($43.41)
$ 50.6517%Add 302.66%66,520
BMYRay Dalio 2013-06-30 Sold Out -0.07%$39.68 - $47.68
($43.41)
$ 50.6517%Sold Out0
BMYPrem Watsa 2013-06-30 Sold Out -0.01%$39.68 - $47.68
($43.41)
$ 50.6517%Sold Out0
BMYVanguard Health Care Fund 2013-03-31 Add0.96%$32.59 - $41.19
($36.62)
$ 50.6538%Add 49.53%17,948,561
BMYRay Dalio 2013-03-31 Add0.05%$32.59 - $41.19
($36.62)
$ 50.6538%Add 267.87%181,140
BMYJohn Hussman 2013-03-31 Sold Out -0.64%$32.59 - $41.19
($36.62)
$ 50.6538%Sold Out0
BMYJames Barrow 2013-03-31 Sold Out -0.05%$32.59 - $41.19
($36.62)
$ 50.6538%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BMY Joel Greenblatt 2014-06-3089,3630.010.05New Buy
BMY Vanguard Health Care Fund 2014-06-3036,197,9612.184.6+22.96%
BMY Ronald Muhlenkamp 2014-06-30212,7700.011.8+0.36%
BMY Dodge & Cox 2014-06-3078,92100-0.25%
BMY Mario Gabelli 2014-06-30674,6850.040.17-1.76%
BMY Jean-Marie Eveillard 2014-06-3014,49200-12.28%
BMY Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
von Autenried PaulSVP, Enterp. Services & CIO 2014-08-19Sell20,000$49.891.52view
Bancroft Charles AEVP & CFO 2014-07-29Sell67,621$51.06-0.8view
Moed Samuel JSVP, Strat Plan & Analysis 2014-07-28Sell25,752$49.322.7view
Caldarella Joseph CSVP & Controller 2014-03-13Sell9,137$55.2-8.24view
ANDREOTTI LAMBERTOCEO 2014-03-10Sell100,000$55.52-8.77view
Schmukler Louis SPres., Global Mfg. & Supply 2014-03-10Sell8,799$55.81-9.25view
CORNELIUS JAMES MDirector 2014-03-05Sell100,000$55.82-9.26view
Schmukler Louis SPres., Global Mfg. & Supply 2014-02-28Sell6,088$54.49-7.05view
Caforio GiovanniEVP & Chief Commercial Officer 2014-02-24Sell41,563$54.44-6.96view
Elicker John ESVP Pub Affairs & Inv Relation 2014-02-19Sell9,534$54.22-6.58view

Press Releases about BMY :

    Quarterly/Annual Reports about BMY:

    News about BMY:

    Articles On GuruFocus.com
    Bristol-Myers: Absolute Valuation Model versus Relative Valuation Model Aug 29 2014 
    Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 
    UnitedHealth Group Up on Weak Day for the Dow Jul 17 2014 
    Pharma Sector Stocks To Consider For Sustained Returns Jun 25 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    A Look at AstraZeneca’s New Drug on Diabetes May 22 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
    Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 21 2014 
    Abbott Capturing Incremental Market Share Mar 18 2014 
    Vanguard Health Care Fund’s Top Five Feb 10 2014 


    More From Other Websites
    Novartis Rises Most in Five Months on Heart-Drug Trial Sep 01 2014
    New Novartis Drug Effective in Treating Heart Failure Aug 30 2014
    Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress:... Aug 30 2014
    Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned Aug 29 2014
    Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance Aug 28 2014
    The Zacks Analyst Blog Highlights: InterMune, Kite Pharma, Amicus, Celgene and Bristol-Myers Squibb Aug 28 2014
    Bristol-Myers Hepatitis C Therapy Approved in EU Aug 27 2014
    [video] Facebook and Movado Downgraded, Deutsche Initiates Drugmakers Aug 27 2014
    Will This Coverage Initiation Affect Bristol-Myers Squibb (BMY) Stock Today? Aug 27 2014
    [$$] Bristol-Myers Hepatitis C Drug Approved in Europe Aug 27 2014
    European Commission Approves Bristol-Myers Squibb’s Daklinza (daclatasvir) Across Multiple... Aug 27 2014
    Merck, Pfizer Combining Drugs In Lung Cancer Study Aug 26 2014
    Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod Aug 22 2014
    Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments Aug 21 2014
    5 companies that will benefit from ALS awareness Aug 21 2014
    FDA clears Eliquis for new use against blood clots Aug 21 2014
    FDA clears Eliquis for new use against blood clots Aug 21 2014
    FDA approves use of Eliquis to treat leg, lung clots Aug 21 2014
    ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms Aug 21 2014
    FDA OKs use of Eliquis to treat leg, lung clots Aug 21 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK